Assessing the impact of the 2017 European LeukemiaNet recommendations on FLT3 allelic ratio calculation and reporting in acute myeloid leukaemia

Br J Haematol. 2022 May;197(3):e35-e37. doi: 10.1111/bjh.18023. Epub 2022 Jan 3.

Authors

Ashley Cartwright¹, Stuart Scott¹, Sebastian Francis², Liam Whitby¹

Affiliations

¹ UK NEQAS for Leucocyte Immunophenotyping, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
² Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

PMID: 34981510
DOI: 10.1111/bjh.18023

No abstract available

Publication types

Letter

MeSH terms

Humans
Leukemia, Myeloid, Acute* / genetics
Mutation
Prognosis
fms-Like Tyrosine Kinase 3 / genetics

Substances

FLT3 protein, human
fms-Like Tyrosine Kinase 3